Jazz’s cannabidiol therapy flunks in Japanese Phase III trial
Jazz’s cannabidiol oral solution, Epidiolex, is approved as an adjunct seizure treatment for three epileptic conditions in the US and Europe.
Jazz’s cannabidiol oral solution, Epidiolex, is approved as an adjunct seizure treatment for three epileptic conditions in the US and Europe.
What's Your Reaction?
